Inhaled Insulin in Development

Bristol-Myers Squibb and QDose have announced a collaboration to develop inhaled insulin.

QDose is now involved in early work on this new form of insulin.

Bristol-Myers Squibb will obtain worldwide exclusive rights to the product and, with skupport from QDose, will take the lead in development, manufacturing and commercialization of the licensed product.

-Bristol-Myers Squibb news release, September 2003

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.